Open access
Sep 2026
Dual-component CAR T cell therapy: targeting BCMA with convertible CAR and MicAbodies
The modularity and flexibility of the cCAR platform, along with the optimization of MA formats and clones, has the potential to enhance functional tuning of CAR T cell therapies, which may support improved efficacy and safety.
Chaitanya Tondepu, Andrew Wong, Clifford Wong et al.
· Antibody Therapeutics · 0 citations